O-024Entrectinib in NTRK-fusion positive gastrointestinal cancers: integrated analysis of patients enrolled in three trials (STARTRK-2, STARTRK-1, and ALKA-372-001). (2nd July 2019) - Siena, S; Demetri, G; Doebele, R; Chae, Y; Conkling, P; Garrido-Laguna, I; Garrido, P; Rolfo, C; Sigal, D; Eng, S; Simmons, B; Ye, C; et al.